Publications
- A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients2023 | Faculty of Medicine in Pilsen
- Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial2023 | Faculty of Medicine in Pilsen
- Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic2022 | Faculty of Medicine in Pilsen
- Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy2019 | Faculty of Medicine in Pilsen
- Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies2019 | Faculty of Medicine in Pilsen
- BK polyomavirus and valganciclovir: Highly suspected association urgently calling for a new randomized trial2019 | Faculty of Medicine in Pilsen
- Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial2018 | Faculty of Medicine in Pilsen
- The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation2017 | Faculty of Medicine in Pilsen
- The future of pharmacotherapy in nephrology2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation2015 | Faculty of Medicine in Pilsen
Loading network view...